Recombinant Human UACA Protein，His

UACA (Uveal Autoantigen Component A) is a protein associated with uveal melanoma, a malignant tumor of the eye that poses significant challenges for diagnosis and treatment. Research into UACA has been propelled by its potential role as a biomarker for early detection of uveal melanoma and its implications in immunotherapy. Uveal melanoma is relatively rare but notorious for its aggressive nature and high rate of metastasis, often spreading to the liver, making early intervention crucial. Recent studies have focused on the structural and functional properties of UACA, highlighting its significance in immune responses and tumor microenvironment interactions. The reorganization of UACA protein, through techniques such as crystallography and protein engineering, aims to elucidate its molecular mechanisms and interactions with other cellular components. Understanding these aspects could pave the way for novel therapeutic strategies that harness the immune system to combat this malignancy or improve diagnostic methods to facilitate earlier detection. As research progresses, the exploration of UACA's multifaceted roles in uveal melanoma and other cancer types remains pivotal in the quest for effective cancer management and immunotherapeutic options.